Today: 3 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb shares rallied this week, trading near $50.55 after news on its Alzheimer’s drug Cobenfy, an AI drug discovery milestone, and a key lawsuit ruling. The company declared a $0.62 quarterly dividend, bringing the annual yield to about 4.9%. Market cap stands at $104 billion. Despite the rebound, BMY shares remain down roughly 15% for 2025.
4 December 2025
··
GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop’s GME.WS warrants surged over 13% in 24 hours, closing at $4.22 on December 4, 2025, with after-hours quotes at $4.26. Issued as a dividend in October, the warrants let holders buy GME shares at $32 until October 2026. Trading volume reached up to 700,000 shares. The move comes ahead of GameStop’s earnings and a “Trade Anything Day” event.
4 December 2025
·
CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

CIBC reported Q4 2025 revenue of C$7.58 billion, up 14% year-over-year, and net income of C$2.18 billion, up 16%. Adjusted earnings per share reached C$2.21, beating analyst estimates. Shares traded near 52-week highs on both TSX and NYSE, with U.S. shares up about 37% year-to-date. The bank raised its dividend and announced leadership changes for 2026.
4 December 2025
···
Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal reported fiscal 2025 net income of C$8.73 billion, up 19% year-over-year, and raised its dividend. Shares traded near multi-year highs, closing at C$177.02 on the TSX and $126.76 USD on the NYSE. Adjusted Q4 net income rose 63% to C$2.51 billion, with credit losses down sharply. The stock’s year-to-date gain outpaced the S&P 500.
4 December 2025
···
Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast, Inc. traded at $35.17 per share with a market cap of $20.68 billion in early December 2025. JPMorgan upgraded the stock to Overweight with a $43 target on December 4, while UBS reiterated a Buy rating and $50 target the same day. BNP Paribas Exane raised its rating to Outperform with a $40 target on December 1. The stock’s valuation remains high, with a trailing P/E in the high-70s to low-80s.
4 December 2025
····
Microsoft (MSFT) Stock News Today, December 4, 2025: AI Sales Jitters, Cloud Strength and 2026 Price Targets

Microsoft (MSFT) Stock News Today, December 4, 2025: AI Sales Jitters, Cloud Strength and 2026 Price Targets

Microsoft shares fell about 2.5% to $477.73 on December 3 after reports said the company lowered growth targets for some AI software sales. Microsoft disputes the claims. The stock trades around 14% below its July 2025 high, with a market cap near $3.85 trillion. Q1 FY26 revenue rose 18% year-over-year to $77.7 billion.
4 December 2025
····
PayPal (PYPL) Stock Today: Selloff After Checkout Warning, AI Commerce Deals and 2025–2026 Forecast

PayPal (PYPL) Stock Today: Selloff After Checkout Warning, AI Commerce Deals and 2025–2026 Forecast

PayPal shares fell 2.6% to $61.24 on December 3, with volume nearly doubling to 24.3 million shares after management flagged slowing branded checkout growth. The stock is down about 20–25% year-to-date and trades well below 2025 highs. Wall Street remains divided, with a consensus “Hold” rating and an average price target near $81.
4 December 2025
··
CRISPR Therapeutics Stock (CRSP) in December 2025: Price, Forecast, CASGEVY Growth and Takeover Rumors

CRISPR Therapeutics Stock (CRSP) in December 2025: Price, Forecast, CASGEVY Growth and Takeover Rumors

CRISPR Therapeutics shares surged 8.5% to $56 on December 3, landing mid-range between their 52-week low of $30 and high of $78. The company reported a $106 million Q3 net loss on $0.9 million in revenue but holds $1.9 billion in cash. Takeover rumors persist, though no formal bids have emerged. Wall Street price targets range widely, with consensus in the high-$60s to mid-$70s.
4 December 2025
·
CenterPoint Energy (CNP) Stock Outlook: Latest News, Forecasts and Catalysts as of December 4, 2025

CenterPoint Energy (CNP) Stock Outlook: Latest News, Forecasts and Catalysts as of December 4, 2025

CenterPoint Energy shares traded at $38.38 on December 4, about 5% below their 52-week high. The company is increasing capital spending and has partnered with Palantir and Nvidia to address electricity demand from AI data centers. Trading volume remains steady, and the stock is viewed as a steady performer by Wall Street. CenterPoint serves over 7 million customers across six states.
4 December 2025
·
Arbe Robotics (ARBE) Stock: Q3 2025 Earnings, Analyst Forecasts and Radar Growth Story – Updated December 4, 2025

Arbe Robotics (ARBE) Stock: Q3 2025 Earnings, Analyst Forecasts and Radar Growth Story – Updated December 4, 2025

Arbe Robotics shares jumped 14.6% to $1.57 on December 4, 2025, after new technology awards and a mixed Q3 report. The company posted Q3 revenue of $254,000, missing expectations but doubling year-over-year, with net loss narrowing to $11 million. Shares remain volatile, trading 85% above their 52-week low but 69% below the high. Market cap stands near $170 million.
4 December 2025
··
Aeva Technologies (AEVA) Soars on Landmark European Automaker Deal: Stock Price, Latest News and 2026 Outlook

Aeva Technologies (AEVA) Soars on Landmark European Automaker Deal: Stock Price, Latest News and 2026 Outlook

Aeva Technologies shares surged 25.7% to $13.69 on December 3 after announcing a decade-long exclusive LiDAR supply deal with a major European automaker, widely believed by analysts to be Mercedes-Benz. The contract covers next-generation Level 3 automated vehicles, with series production set for 2028 and potential lifetime revenue exceeding $1 billion.
4 December 2025
··
Salesforce (CRM) Stock Today: Record Q3 FY26 Earnings, AI Agentforce Surge and Fresh Price Targets – December 4, 2025

Salesforce (CRM) Stock Today: Record Q3 FY26 Earnings, AI Agentforce Surge and Fresh Price Targets – December 4, 2025

Salesforce shares rose about 1.7% to $238–239 after reporting record Q3 FY26 results and raising full-year guidance. Non-GAAP EPS reached $3.25, beating estimates by over 13%, with non-GAAP operating margin at 35.5%. Revenue climbed to $10.3 billion, up 9% year over year. AI platforms Agentforce and Data 360 surpassed $1.4 billion in annual recurring revenue.
4 December 2025
···
Serve Robotics (SERV) Stock Soars on Trump Robotics Push and Q3 Growth: Price, Forecasts and Risk Outlook as of December 4, 2025

Serve Robotics (SERV) Stock Soars on Trump Robotics Push and Q3 Growth: Price, Forecasts and Risk Outlook as of December 4, 2025

Serve Robotics shares jumped 18.2% to $11.80 on December 3, 2025, after reports that President Trump may issue an executive order to boost robotics development. Trading volume doubled, and pre-market quotes showed further gains. Q3 revenue rose 209% year-over-year to $687,000, but the company continues to post heavy losses as it expands its delivery robot network.
4 December 2025
··
Capricor Therapeutics (CAPR) Soars After HOPE‑3 Win: Latest News, Analyst Targets and Stock Forecast as of December 4, 2025

Capricor Therapeutics (CAPR) Soars After HOPE‑3 Win: Latest News, Analyst Targets and Stock Forecast as of December 4, 2025

Capricor Therapeutics shares surged over 300% to nearly $30 after Phase 3 data showed its Deramiocel cell therapy slowed upper-limb decline by 54% and preserved 91% of heart function in Duchenne muscular dystrophy patients. The HOPE-3 trial enrolled 106 mostly non-ambulatory boys and young men. Trading was volatile, with the stock flagged as “extremely overbought.”
4 December 2025
··
Hormel Foods (HRL) Stock Rises After Q4 2025 Earnings Miss but Strong 2026 Guidance

Hormel Foods (HRL) Stock Rises After Q4 2025 Earnings Miss but Strong 2026 Guidance

Hormel Foods reported a rare GAAP loss for its fiscal fourth quarter, citing $234 million in non-cash impairment charges, but raised its earnings outlook for 2026. Net sales rose 4% to $3.2 billion, while adjusted EPS of $0.32 beat estimates. Hormel shares traded around $23 after earnings, still down about 25–30% over the past year. The company announced its 60th consecutive annual dividend increase.
4 December 2025
··
Meta Platforms (META) Stock on December 4, 2025: EU WhatsApp AI Probe, Massive Capex, and Fresh 2025–2030 Price Targets

Meta Platforms (META) Stock on December 4, 2025: EU WhatsApp AI Probe, Massive Capex, and Fresh 2025–2030 Price Targets

Meta Platforms shares traded around $640 midday December 4, with a market cap near $1.8 trillion, about 20% below October’s record high. The company faces a new EU antitrust probe into WhatsApp AI, surging AI capex that could top $100 billion annually, and mixed analyst forecasts. Q3 revenue rose 26% to $51.24 billion, but net income was hit by a $15.93 billion tax charge. Core ad business remains strong.
4 December 2025
·
Nauticus Robotics (KITT) Stock Explodes 116%: Debt Swap, Delisting Risk and Long-Term Forecasts as of December 4, 2025

Nauticus Robotics (KITT) Stock Explodes 116%: Debt Swap, Delisting Risk and Long-Term Forecasts as of December 4, 2025

Nauticus Robotics (NASDAQ: KITT) shares jumped 116% on December 3, closing at $1.56 after heavy trading, but the stock remains far below previous years’ levels. The company is restructuring debt, secured a $250 million equity facility, and faces Nasdaq delisting pressure. Q3 2025 revenue rose to $2 million, but the firm posted a $6.6 million net loss. Short-term and long-term forecasts for KITT remain sharply divided.
4 December 2025
··
1 … 534 535 536 537 538 … 584
Go toTop